Mkts

Charles River Laboratories International, Inc.

NYSE: CRL
$357.37+19.85 (+5.88%)
As of Nov 9, 3:30 PM ET

Key statistics

Day range
342.00358.76
52-week range
146.20379.63
Today
Open343.22
Previous close357.37
Volume—
Valuation
Market cap16.17B
P/E ratio402.45×
EPS (TTM)0.90
Income & risk
Dividend / yield—
Beta1.35
Avg volume1.01M
Discussion

CRL News

Stories mentioning CRL from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 28Q4 '25Dec 27Q3 '25Sep 27Q2 '25Jun 28Q1 '25Mar 29Q4 '24Dec 28Q3 '24Sep 28Q2 '24Jun 29
Income Statement
Revenue995,830994,2271,004,8521,032,135984,1681,002,5491,009,7631,026,117
Cost of Goods Sold660,742672,404
Gross Profit349,021353,713
Operating Expenses
Research & Development
Sales General & Admin159,422196,136177,589191,549177,799195,708199,213169,791
Total Operating Expenses
Operating Income (Loss)119,897(283,440)133,799100,13474,669(167,687)117,405151,652
Interest Income1,0331,0171,4221,0971,4041,8351,5283,010
Interest Expense
Other Expense(124,130)12,099(22,618)154.00(12,211)(22,705)2,592(2,240)
Pretax Income
Tax Provision(15,140)(17,809)31,64418,72510,100(3,044)20,94625,392
Net Income (Loss)(14,843)(276,555)54,42252,32625,469(214,495)69,65794,081
Earnings Per Share (Basic)(0.30)(5.58)1.111.060.50(4.17)1.341.75
Earnings Per Share (Diluted)(0.30)(5.58)1.101.060.50(4.15)1.331.74
Weighted Average Shares Outstanding (Basic)48,95149,56449,21349,14950,67751,38051,39451,551
Weighted Average Shares Outstanding (Diluted)48,95149,56449,42649,31650,85351,62851,58351,846

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CRL

Charles River Laboratories International, Inc. (NYSE: CRL) is a stock listed on the New York Stock Exchange under the ticker symbol CRL. It last traded at $357.37 (Nov 9, 2026, 3:30 PM ET), up 5.9% on the day. That gives Charles River Laboratories International a market capitalisation of $16.2B and a price-to-earnings ratio of 402.4.

Over the past 52 weeks CRL has traded between $146.20 and $379.63.

Revenue for the quarter ended Mar 28, 2026 was $995.8M; a net loss of $14.8M. Revenue was up 1.2% from $984.2M in the quarter ended Mar 29, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 28, 2026$995.8M-$14.8M-1.5%
Dec 27, 2025$994.2M-$276.6M-27.8%
Sep 27, 2025$1.0B$54.4M5.4%
Jun 28, 2025$1.0B$52.3M5.1%

From Charles River Laboratories International’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…